Back to BMRNView full pipeline
Phase 1/2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Phenylketonuria
View Full LandscapeDrug Information
Target Indication
Phenylketonuria
Mechanism of Action
Gene Therapy
Clinical Trial
NCT05235620Last updated: 12/3/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterinPhase 3
Phenylketonurias
MiglustatPhase 3
Pompe Disease (Late-onset)
BMN 110 - WeeklyPhase 3
Mucopolysaccharidosis IV A
Cipaglucosidase AlfaPhase 3
Pompe Disease (Late-onset)
Valoctocogene roxaparvovecPhase 3
Hemophilia A With Inhibitor
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts